Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables.
from Latest News Business on Firstpost https://ift.tt/2DYANT5
Tuesday, 27 November 2018
Sun Pharma to acquire Japan's Pola Pharma for $1 mn; to strengthen presence in dermatology segment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment